TDOC vs TEM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TDOC · Teladoc Health$7.45 ▼ 4.36%
TEM · Tempus AI$54.04 ▼ 9.34%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TDOC +2.8%
- TEM -29.0%
Head to head
| Metric | TDOC | TEM |
|---|---|---|
| Price | $7.45 | $54.04 |
| Change today | ▼ 4.36% | ▼ 9.34% |
| Market cap | $1.36B | $9.86B |
| Return, 3 months | +20.2% | -18.3% |
| Return, year to date | +6.4% | -8.5% |
| Return, 1 year | +7.0% | -23.1% |
| P/E (TTM) | – | – |
| P/B | 1.0 | 19.7 |
| P/E percentile vs own 5y | 12th | 25th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -3.4% | +23.1% |
| Net profit growth (YoY) | +45.6% | +81.4% |
| Gross margin | 68.6% | 64.5% |
| Operating margin | -5.4% | -18.5% |
| Net margin | -6.3% | -12.5% |
| Return on equity | -11.5% | -37.5% |
| Analyst target vs. price | +26.7% | +63.8% |
| Analyst buy share | 33% | 62% |
| RSI (14) | 44 | 33 |
| 30-day volatility | 91.1% | 90.9% |
| Max drawdown, 1 year | -44.1% | -46.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TEM is the largest of the group by market value.
- TDOC has returned the most over the past year.
- TEM is growing revenue fastest.
- TDOC keeps the most profit per dollar of sales.
- TEM has been the calmest stock over the last 30 days.